AXIM BIOTECHNOLOGIES, INC. Retained Earnings
AXIM BIOTECHNOLOGIES, INC. (AXIM) had Retained Earnings of -$74.75 million as of 2024-06-30, per its 10-Q filed 2024-08-19.
Discontinued › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest › Equity, Attributable to Parent
us-gaap:RetainedEarningsAccumulatedDeficit · last filed 2024-08-19
- 2024-06-30: Retained Earnings (Accumulated Deficit) -$74.75M.
- 2024-03-31: Retained Earnings (Accumulated Deficit) -$72.48M.
- 2023-12-31: Retained Earnings (Accumulated Deficit) -$72.18M.
- 2023-09-30: Retained Earnings (Accumulated Deficit) -$70.28M.
| Period end | Retained Earnings (Accumulated Deficit) |
|---|---|
| 2024-06-30 | -$74.75M 10-Q · filed 2024-08-19 |
| 2024-03-31 | -$72.48M 10-Q/A · filed 2024-05-22 |
| 2023-12-31 | -$72.18M 10-Q · filed 2024-08-19 |
| 2023-09-30 | -$70.28M 10-Q · filed 2023-11-20 |
| 2023-06-30 | -$70.61M 10-Q · filed 2023-08-21 |
| 2023-03-31 | -$66.89M 10-Q · filed 2023-05-22 |
| 2022-12-31 | -$64.13M 10-K · filed 2024-04-16 |
| 2022-09-30 | -$63.23M 10-Q/A · filed 2022-11-15 |
| 2022-06-30 | -$61.19M 10-Q · filed 2022-08-16 |
| 2022-03-31 | -$59.97M 10-Q · filed 2022-05-23 |
| 2021-12-31 | -$57.88M 10-K · filed 2023-04-17 |
| 2021-09-30 | -$49.83M 10-Q · filed 2021-11-22 |
| 2021-06-30 | -$46.54M 10-Q · filed 2021-08-23 |
| 2021-03-31 | -$42.71M 10-Q/A · filed 2021-06-02 |
| 2020-12-31 | -$41.85M 10-K/A · filed 2022-04-19 |
| 2020-09-30 | -$39.45M 10-Q/A · filed 2020-11-27 |
| 2020-06-30 | -$37.55M 10-Q/A · filed 2020-08-18 |
| 2020-03-31 | -$37.47M 10-Q/A · filed 2020-07-02 |
| 2019-12-31 | -$35.44M 10-K/A · filed 2021-04-26 |
| 2019-09-30 | -$34.00M 10-Q · filed 2019-11-14 |
| 2019-06-30 | -$33.14M 10-Q · filed 2019-08-14 |
| 2019-03-31 | -$31.34M 10-Q · filed 2019-05-15 |
| 2018-12-31 | -$28.99M 10-K/A · filed 2020-05-20 |
| 2018-09-30 | -$28.01M 10-Q · filed 2018-11-14 |
| 2018-06-30 | -$26.68M 10-Q · filed 2018-08-17 |
| 2018-03-31 | -$25.00M 10-Q · filed 2018-05-18 |
| 2017-12-31 | -$22.24M 10-K · filed 2019-04-08 |
| 2017-09-30 | -$20.80M 10-Q · filed 2017-11-20 |
| 2017-06-30 | -$19.16M 10-Q · filed 2017-09-14 |
| 2017-03-31 | -$18.59M 10-Q · filed 2017-09-14 |
| 2016-12-31 | -$18.07M 10-K · filed 2018-03-15 |
| 2016-09-30 | -$16.89M 10-Q · filed 2016-11-30 |
| 2016-06-30 | -$13.63M 10-Q · filed 2016-08-25 |
| 2016-03-31 | -$11.74M 10-Q · filed 2016-05-26 |
| 2015-12-31 | -$10.78M 10-K · filed 2017-09-14 |
| 2015-09-30 | -$4.46M 10-Q · filed 2015-11-23 |
| 2015-06-30 | -$2.76M 10-Q · filed 2015-08-27 |
| 2014-12-31 | -$691.96K 10-K · filed 2016-04-18 |
| 2013-09-30 | -$66.05K 10-Q · filed 2013-11-18 |
| 2013-06-30 | -$55.41K 10-Q · filed 2013-08-14 |
| 2013-03-31 | -$25.61K 10-Q · filed 2013-05-15 |
| 2012-12-31 | -$19.80K 10-Q · filed 2013-11-18 |
| 2012-09-30 | -$3.25K 10-Q · filed 2012-11-19 |
| 2012-06-30 | -$5.64K 10-Q · filed 2012-08-14 |
| 2012-03-31 | -$5.40K 10-Q · filed 2012-05-17 |
| 2011-12-31 | -$4.89K 10-K · filed 2013-04-15 |
| 2011-09-30 | -$6.11K 10-Q/A · filed 2011-11-21 |
| 2010-12-31 | -$2.10K 10-K/A · filed 2012-05-01 |